Low-CArbohydrate Diet and SGLT2-INhibitOr to Achieve Moderate Ketosis in Healthy Volunteers

NCT05662865 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Ketones, Metabolism

Interventions

DRUG: SGLT2 inhibitor
OTHER: Controlled, Adaptive Study Diet

Sponsor

AdventHealth Translational Research Institute